Sacklers withdrew over $10 billion in a decade from Purdue Pharma: NYT

The Sackler family – owners of Purdue Pharma – transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing a new audit commissioned by the drugmaker.